RecruitingPhase 3NCT07146022
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Veradermics, Inc.
- Principal Investigator
- Reid Waldman, M.D., MDVeradermics, Inc.
- Intervention
- VDPHL01 QD(drug)
- Enrollment
- 552 target
- Eligibility
- 18-65 years · FEMALE
- Timeline
- 2025 – 2028
Study locations (30)
- Site 73, Birmingham, Alabama, United States
- Site 89, Birmingham, Alabama, United States
- Site 77, Phoenix, Arizona, United States
- Site 30, Fort Smith, Arkansas, United States
- Site 69, Encino, California, United States
- Site 2, Fremont, California, United States
- Site 64, Manhattan Beach, California, United States
- Site 93, Northridge, California, United States
- Site 66, Santa Monica, California, United States
- Site 34, Sherman Oaks, California, United States
- Site 94, Thousand Oaks, California, United States
- Site 21, Vista, California, United States
- Site 5, Castle Rock, Colorado, United States
- Site 24, Greenwood Village, Colorado, United States
- Site 17, Aventura, Florida, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07146022 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07533006A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)Eli Lilly and Company
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC